CN111617025A - Fermentation product cosmetic for whitening, removing freckles and resisting saccharification - Google Patents
Fermentation product cosmetic for whitening, removing freckles and resisting saccharification Download PDFInfo
- Publication number
- CN111617025A CN111617025A CN202010540446.9A CN202010540446A CN111617025A CN 111617025 A CN111617025 A CN 111617025A CN 202010540446 A CN202010540446 A CN 202010540446A CN 111617025 A CN111617025 A CN 111617025A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- whitening
- lactobacillus crispatus
- parts
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 67
- 230000004151 fermentation Effects 0.000 title claims abstract description 67
- 230000002087 whitening effect Effects 0.000 title claims abstract description 28
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 22
- 239000002537 cosmetic Substances 0.000 title claims abstract description 17
- 206010014970 Ephelides Diseases 0.000 title claims abstract description 14
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 37
- 241000218492 Lactobacillus crispatus Species 0.000 claims abstract description 36
- 239000000284 extract Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000047 product Substances 0.000 claims abstract description 19
- 235000012754 curcumin Nutrition 0.000 claims abstract description 18
- 229940109262 curcumin Drugs 0.000 claims abstract description 18
- 239000004148 curcumin Substances 0.000 claims abstract description 18
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001963 growth medium Substances 0.000 claims abstract description 17
- 238000009630 liquid culture Methods 0.000 claims abstract description 8
- 239000000706 filtrate Substances 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 34
- 241000196324 Embryophyta Species 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 3
- 229910052564 epsomite Inorganic materials 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 3
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 229910001868 water Inorganic materials 0.000 abstract description 7
- 230000001815 facial effect Effects 0.000 abstract description 5
- 239000006071 cream Substances 0.000 abstract description 2
- 239000006210 lotion Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 32
- 230000005764 inhibitory process Effects 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 102000003425 Tyrosinase Human genes 0.000 description 14
- 108060008724 Tyrosinase Proteins 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 11
- 238000006206 glycosylation reaction Methods 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 230000013595 glycosylation Effects 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036252 glycation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical group CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 229920002444 Exopolysaccharide Polymers 0.000 description 2
- 208000003367 Hypopigmentation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 125000005594 diketone group Chemical group 0.000 description 2
- 230000003425 hypopigmentation Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 210000002780 melanosome Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 206010001557 Albinism Diseases 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164439 Curcuma angustifolia Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- HEILIGJNYTWOHU-UHFFFAOYSA-N ethanol 2-hydroxybenzoic acid Chemical compound CCO.OC(=O)C1=CC=CC=C1O HEILIGJNYTWOHU-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- -1 hydroxyl free radical Chemical class 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a fermented product cosmetic for whitening, removing freckles and resisting saccharification, which comprises the following steps: (1) inoculating, fermenting and culturing the preserved lactobacillus crispatus CGMCC No.6364 into a seed solution under the aseptic condition; (2) inoculating 10 v/v% of lactobacillus crispatus CGMCC No.6364 seed solution to a liquid culture medium containing cortex mori extract and curcumin for fermentation culture; (3) centrifuging the fermentation liquor obtained in the step (2) at a centrifugal rotation speed of 8000r/min for 30min, collecting supernatant to obtain fermentation filtrate, filtering with a 0.22um sterilizing filter, and further making into facial mask, essence, cosmetic water, lotion, and cream.
Description
Technical Field
The invention relates to the technical field of cosmetic formulas, in particular to a plant fermentation composition for whitening, removing freckles and resisting saccharification and an application thereof in a fermentation product cosmetic for whitening, removing freckles and resisting saccharification.
Background
The color of human skin can therefore take on different shades, not depending on the number of melanocytes, but on the amount of various melanosomes produced, depending on the number, size, distribution and degree of melanosomes. The formation and deposition of normal melanin in melanocytes not only has the functions of protecting skin, resisting ultraviolet radiation, preventing internal tissues from overheating, and the like, but also has important significance on the health and beauty of skin. When abnormal changes such as hyperpigmentation, hypopigmentation or hypopigmentation occur in the skin, different types of dyschromatosis skin diseases such as vitiligo, albinism, chloasma, etc. are caused, and a corresponding unpleasant psychological sensation is produced.
Senescence-associated glycation is in fact a abbreviation, known collectively as non-enzymatic glycosylation, and in brief, the glycation reaction is the binding of sugars to proteins in the absence of enzymatic action, causing the proteins to lose normal structure and color, become brittle, and yellow. The protein may be of various types, including hemoglobin, elastin, collagen, and the like. The dermis layer of the skin contains a lot of collagen, so the skin is tight and elastic. After the reaction between sugars (glucose and fructose) and collagen, reversible primary glycosylation products are formed, followed by the formation of irreversible advanced glycosylation end products (AGEs). After glycation of collagen, in addition to further aging of the skin, the skin also looks yellow and therefore loses its fair texture. Not only does glycation occur in the dermis, new studies have found that proteins in the epidermis (particularly keratin) can also be glycated. In addition, AGEs can stimulate AGEs receptors and promote the production of melanin.
The whitening product in the prior art is usually only researched for inhibiting the activity of tyrosinase, and the invention aims to provide a plant fermentation composition for whitening, removing freckles and resisting saccharification and an application thereof in cosmetics.
Disclosure of Invention
In view of the above problems, the present invention aims to provide a plant fermentation composition for whitening, removing spots and resisting saccharification, and its application in cosmetics. The pure plant culture medium is safe and reliable, and is matched with probiotic fermentation, so that the inhibitory activity of the neuraminidase can be improved unexpectedly, and a good anti-saccharification effect and an anti-oxidation effect can be obtained, so that the effects of whitening, removing freckles and resisting aging are achieved.
Lactobacillus, lactic acid bacteria, are well-established probiotics and their fermentation products (usually lysates) have a certain cosmetic effect. It is known to those skilled in the art that the metabolism of probiotics is regulated in many ways, and the metabolites include many bioactive substances, such as small peptides, exopolysaccharides, saponins, amino acids, minerals, phenols, etc. The specific structure of exopolysaccharide greatly influences the physiological activity. In contrast, the team of the invention carries out a great amount of screening on the strains and improvement on the culture process so as to obtain the fermentation process with outstanding beauty effect.
Chinese patent 2013100043553 discloses a strain of Lactobacillus crispatus, which is a strain of Lactobacillus crispatus, characterized in that the preservation number of the strain is CGMCC No. 6364. The known function of the strain is to effectively realize antagonism to various pathogenic bacteria, and in addition, the strain has higher adhesion capability to vaginal epithelial cells and higher lactic acid production capability. The group of the invention finds that the lactobacillus strain has great potential as a strain of lactobacillus which is not commonly used in cosmetics, and the active extract of the conventional fermentation product has good antioxidant effect and certain activity of inhibiting the tyrosinase. The plant fermentation product is characterized by plasticity, and the fermentation process is tried to be changed, so that the addition of some plant components can obviously improve various cosmetic effects, including anti-saccharification performance, whitening performance and the like. While we observed that other strains of Lactobacillus crispatus did not have such outstanding plasticity properties.
Curcumin is a chemical component extracted from the rhizome of some plants in the families of Zingiberaceae and Araceae, wherein the Curcuma rhizome contains about 3-6% of pigment with diketone, which is a rare pigment with diketone in the plant world. Curcumin is orange yellow crystal powder, slightly bitter in taste and insoluble in water, and is mainly used for coloring products such as sausage products, cans, sauced and marinated products and the like in food production. The medical research shows that curcumin has the effects of reducing blood fat, resisting tumor, resisting inflammation, benefiting gallbladder, resisting oxidation and the like. The team of the invention tries to add a certain amount of curcumin into the culture medium, and finds that the performance of the fermentation product can be greatly changed.
The cortex mori radicis a traditional Chinese medicinal material, is root bark of mulberry, contains a large amount of nutrient substances, can promote metabolism of a body, and has a repairing effect on cells, so that the cortex mori radicis has a certain removing effect on scars, can enable the skin to become finer and smoother, and has good beautifying effect. The invention adds the cortex mori aqueous extract into the culture medium, and finds that the cortex mori aqueous extract and the curcumin can synergistically improve the beauty effect of the lactobacillus crispatus CGMCC No.6364 fermentation product. In addition, the cortex mori radicis also has certain beautifying effect and has double functions of regulating and controlling the growth of microorganisms and directly acting on the skin for beautifying.
In order to achieve the purpose, the invention is realized by the following technical scheme:
the plant fermentation composition for whitening, removing freckles and resisting saccharification is characterized by comprising the following preparation methods:
(1) inoculating the preserved Lactobacillus crispatus CGMCC No.6364 into MRS culture medium under aseptic condition, culturing at 35 deg.C and 200rpm for 12 hr to obtain culture as seed liquid for fermentation culture with final concentration of 6 × 107cfu/ml;
(2) Inoculating lactobacillus crispatus CGMCC No.6364 seed liquid into a liquid culture medium according to the inoculation amount of 10 v/v%, and performing shake table culture at 30 ℃ and 200rpm for 24 hours;
the preparation method of the liquid culture medium comprises the following steps: mixing 0.3g curcumin, 50mL cortex Mori extractive solution, 25g glucose, 8g peptone, 7g yeast extract, 8g beef extract, 5g sodium acetate, 2g ammonium citrate, 2mL tween-80, 0.6g MgSO4·7H2O, 0.3g of MnSO4·4H2O, 2g of K2HPO4Mixing with 1000mL of distilled water, adjusting the pH value to 6.2-6.4, and sterilizing by high pressure steam to obtain a sterile culture medium;
(3) and (3) centrifuging the fermentation liquor obtained in the step (2) at a centrifugal rotation speed of 8000r/min for 30min, collecting supernatant to obtain fermentation filtrate, and filtering the fermentation filtrate by using a 0.22um sterilizing filter to obtain a sterile fermentation composition.
The invention also provides a cosmetic which contains the plant fermentation composition for whitening, removing freckles and resisting saccharification.
Preferably, the cosmetic formulation may be a mask, a serum, a cream, etc.
Compared with the prior art, the invention has the following beneficial effects:
the active ingredient of the cosmetic is prepared by fermenting natural and safe substrates with screened probiotics, is wider in applicable population, has no obvious toxic or side effect, has no irritation, has obvious anti-saccharification and whitening effects, and also has good antioxidant activity. As a preferred embodiment, the facial mask can be used for facial masks, is convenient to use and has an excellent effect.
Detailed Description
The present invention will be further described in detail with reference to the following specific examples, which are provided for illustration only and are not intended to limit the scope of the present invention. The test methods used in the following examples are all conventional methods unless otherwise specified; the materials, reagents and the like used are, unless otherwise specified, commercially available reagents and materials.
The cortex mori radicis extract of the present example is commercially available from shanxi kang jumping biotechnology limited.
Example 1
The plant fermentation composition for whitening, removing freckles and resisting saccharification is characterized by comprising the following preparation methods:
(1) inoculating the preserved Lactobacillus crispatus CGMCC No.6364 into MRS culture medium at 1 v/v%, culturing at 35 deg.C and 200rpm for 12 hr to obtain culture as seed liquid for fermentation culture with final concentration of 6 x 107cfu/ml;
(2) (2) inoculating lactobacillus crispatus CGMCC No.6364 seed liquid into a liquid culture medium according to the inoculation amount of 10 v/v%, and performing shake table culture at 30 ℃ and 200rpm for 24 hours;
the preparation method of the liquid culture medium comprises the following steps: mixing 0.3g curcumin, 50mL cortex Mori extractive solution, 25g glucose, 8g peptone, 7g yeast extract, 8g beef extract, 5g sodium acetate, 2g ammonium citrate, 2mL tween-80, 0.6g MgSO4·7H2O, 0.3g of MnSO4·4H2O, 2g of K2HPO4Mixing with 1000mL of distilled water, adjusting the pH value to 6.2-6.4, and sterilizing by high pressure steam to obtain a sterile culture medium;
(3) and (3) centrifuging the fermentation liquor obtained in the step (2) at a centrifugal rotation speed of 8000r/min for 30min, collecting supernatant to obtain fermentation filtrate, and filtering the fermentation filtrate by using a 0.22um sterilizing filter to obtain a sterile fermentation composition.
Example 2 comparative example
The research and development team finds that curcumin and the cortex mori radicis have the functions of synergistically increasing the oxidation resistance, whitening and anti-saccharification performance of the fermented extract.
Comparative example 1
The experimental method is the same as that of example 1, but the fermentation medium is not added with curcumin and cortex mori radicis extract, and the rest is unchanged.
Comparative example 2:
the experimental procedure was the same as in example 1, except that no curcumin was added to the fermentation medium, and the rest was unchanged.
Comparative example 3:
the experimental procedure was the same as in example 1, except that the fermentation medium was not supplemented with the cortex Mori extract, and the rest was unchanged.
Comparative example 4:
the experimental method is the same as that of example 1, but the Lactobacillus crispatus CGMCC No.6364 is replaced by the Lactobacillus crispatus CGMCC1.2743, and the others are not changed.
Example 3
And (3) testing the cytotoxicity:
the plant fermentation composition obtained in example 1 is dissolved in serum-free DMEM culture solution, 4 samples are prepared respectively, the mass fractions of the samples are 0.25%, 0.5%, 1% and 2%, MTT detection is performed by taking the serum-free DMEM culture solution as a negative control sample group, and the cytotoxicity of the whitening, freckle-removing and anti-saccharification plant fermentation composition is evaluated.
L929 cells were seeded at 100. mu.L/well in 96-well plates at 1 × 105one/mL, 5% CO at 37 ℃2And after 24 hours of culture in serum-free DMEM culture solution for adherence, removing the culture solution by suction, adding 100 mu L of sample solution with different mass fractions into each hole, and continuously culturing the negative control sample group in serum-free DMEM for 48 hours by a conventional method. Then 20. mu.L of 5mg/mL MTT solution was added, and the mixture was incubated in an incubator for 4 hours in the absence of light. The supernatant was discarded and added to DMSO in an amount of 100. mu.L, and the mixture was shaken on a shaker at a low speed for 20min to measure the absorbance at a wavelength of 570 nm. The other groups of cells were calculated as followsRelative survival (β) results are shown in table 1.
β=An/A0
In the formula, An is the absorbance of the experimental group, A0Absorbance of negative control group
TABLE 1 cytotoxicity assays
| Relative cell survival (%) | 0.25% | 0.5% | 1% | 2% |
| EXAMPLE 1 group | 96.37±8.56 | 93.43±7.55 | 91.55±9.27 | 90.72±6.51 |
According to ISO 10993-5: 2009, the cell viability was greater than 70% and was considered non-toxic. As can be seen from the above results, the plant fermentation composition of the present invention has a higher cell viability than 90% at the selected mass concentration, considering its non-cytotoxicity.
Example 4
And (3) evaluating the hydroxyl radical scavenging capacity of the plant fermentation composition for whitening, removing freckles and resisting saccharification.
Antioxidation refers to the abbreviation of antioxidant free radical, Anti-Oxidant. The human body continuously generates free radicals in the human body due to continuous contact with the outside, including respiration (oxidation reaction), external pollution, radiation irradiation and other factors. Scientific studies have shown that cancer, aging or other diseases are mostly associated with the production of excess free radicals. Research on antioxidation can effectively overcome the harm caused by the antioxidation, so the antioxidation is listed as one of the main research and development directions by health-care products and cosmetic enterprises, and is also one of the most important functional requirements of the market. Antioxidant effects are well recognized as indicative of anti-aging effects.
Vitamin C is selected as a positive control group for administration, and the groups of example 1, comparative examples 1-4 and V are setCAnd (4) grouping. Dissolving the above components with purified water to obtain sample solutions with concentration of 15ug/ml, 25ug/ml, 35ug/ml, 45ug/ml and 55ug/ml, adding sample, FeSO 4.7H2O solution (4.5mmol/L), salicylic acid-ethanol solution and H2 according to the preparation method of A, A1 and A22O2Mixing the solutions (4.4mmol/L), warm bathing in a constant temperature water bath at 37 deg.C in dark for 30min, and measuring absorbance at 510 nm;
hydroxyl radical scavenging rate (%) [1- (A1-A2)/A0] X100%
A0: 1.0ml of FeSO4 & 7H2O +1.0ml of salicylic acid +1.0ml of hydrogen peroxide +1.0mLH2O
A1: 1.0mL FeSO4 & 7H2O +1.0mL salicylic acid +1.0mL hydrogen peroxide +1.0mL sample
A2: 1.0mL FeSO4 & 7H2O +1.0mL salicylic acid +1.0mL H2O +1.0mL sample
The relevant test data are shown in table 2:
TABLE 2 various groups of different concentrations of scavenging ability for hydroxyl radical
As can be seen from the test data in table 2, example 1 has a higher hydroxyl radical scavenging ability as compared with the positive test group using Vc; the lactobacillus crispatus CGMCC No.6364 is contained, but the clearance rate of the culture solution fermented by the extract containing curcumin or the white mulberry root-bark is better than that of the simple lactobacillus crispatus CGMCC No.6364 (the clearance rate of the group of comparative example 2 and the group of comparative example 3 is more than that of the comparative example 1); the lactobacillus crispatus CGMCC No.6364 is replaced by the lactobacillus crispatus CGMCC1.2743 for fermentation (other culture conditions are not changed), the effect of removing free radicals is the worst, even the effect is inferior to the effect of simple lactobacillus crispatus CGMCC No.6364 fermentation, which shows that the active extract of the conventional fermentation product of the lactobacillus crispatus CGMCC No.6364 has better hydroxyl free radical removing capability, and the effect can be obviously improved by adding curcumin or a cortex mori extract, while the lactobacillus crispatus of other strains has no outstanding effect.
Example 5
Inhibition of non-enzymatic glycosylation assays
The test simulates the non-enzymatic glycosylation reaction in human body by mixing and incubating bovine serum albumin and fructose, the inhibitor of the non-enzymatic glycosylation reaction is added to inhibit the reaction, the fluorescence intensity of the system with the added inhibitor is weaker than that of the control without the added inhibitor, and the inhibition rate is used for reflecting the inhibition condition of the sample on the non-enzymatic glycosylation reaction. A certain amount of a mixed solution containing 10mg/mL bovine serum albumin and 0.25mol/L fructose was taken as a reaction solution. PBS (1% by mass) solution of example 1 and comparative examples 1-4 was prepared as a treatment group, and a positive control group (1.00% by mass of Vc ethyl ether), a negative control group (PBS instead of sample) and a blank group (PBS instead of reaction solution) were set, each group having 3 parallel tubes. Incubate at 37 ℃ in the dark. The Fluorescence intensity (RFU) of each test group was measured at 370nm (absorption wavelength)/440 nm (excitation wavelength) using a Fluorescence microplate reader selected from items 1, 3, 5 and 7d, and the inhibition ratio was calculated. The results are shown in Table 3.
Inhibition (%) [1- (RFU inhibition group-RFU blank group)/RFU negative control group ] × 100%
TABLE 3 results of inhibition of non-enzymatic glycosylation in each experimental group
| Relative inhibition rate | D1 | D3 | D5 | D7 |
| Positive group (%) | 40.3±2.3 | 50.6±4.7 | 57.0±4.1 | 62.8±7.7 |
| Example 1 group (%) | 47.6±5.1 | 58.8±6.7 | 70.3±5.1 | 73.8±4.3 |
| Comparative example 1 group (%) | 12.2±1.3 | 15.6±1.4 | 16.2±2.6 | 18.4±2.0 |
| Comparative example 2 group (%) | 14.3±1.8 | 18.4±1.9 | 18.5±1.7 | 21.7±1.8 |
| Comparative example 3 group (%) | 15.4±1.5 | 17.4±1.7 | 20.7±1.5 | 22.8±3.1 |
| Comparative example 4 group (%) | 5.3±0.63 | 6.4±0.9 | 7.3±1.1 | 9.3±2.3 |
As can be seen from Table 4, the inhibition rate of the non-enzymatic glycosylation reaction was gradually increased by the respective experimental groups with the increase of the incubation time.
Example 1 compared with the positive test group, the inhibition rate of the non-enzymatic glycosylation reaction is higher; the lactobacillus crispatus CGMCC No.6364 is contained, but the inhibition rate of the culture solution containing curcumin or cortex mori radicis extract fermentation is better than that of the simple lactobacillus crispatus CGMCC No.6364 fermentation culture (the inhibition rates of the comparative example 2 group and the comparative example 3 group are higher than that of the comparative example 1); and the lactobacillus crispatus CGMCC No.6364 is replaced by the lactobacillus crispatus CGMCC1.2743 for fermentation (other culture conditions are not changed), and the inhibition rate is lowest. The active extract of the conventional fermentation product of lactobacillus crispatus CGMCC No.6364 has better inhibition rate of non-enzymatic glycosylation, and has good synergistic effect by adding curcumin or cortex mori extract, so that the inhibition rate of non-enzymatic glycosylation can be improved. Other strains of Lactobacillus crispatus did not have such outstanding efficacy.
Example 5
Inhibition of tyrosinase in vitro experiments:
PBS solution is used for preparing 1mg/ml tyrosinase solution and 200U/ml tyrosinase solution. Example 1 and comparative examples 1 to 4 were designed as treatment groups, and vitamin C ethyl ether solution was a positive control group. The fermentation composition and the vitamin C ethyl ether solution of the treatment group were prepared using PBS to 4 experimental concentrations with mass fractions of 0.25%, 0.5%, 1%, 2%, respectively.
And (3) enzyme activity detection: transferring four groups of sample solutions a, b, c and d according to the table 3 by using a micropipette, placing the sample solutions in a 1.5ml EP tube (the reaction system is prepared into 1000u1), and carrying out water bath at 35 ℃ for 10 min; adding 200ul tyrosinase solution, carrying out water bath at 35 ℃ for 30min, respectively taking 150ul tyrosinase solution from each reaction tube, adding the solution into a 96-well plate, and measuring the absorbance A value at 475nm by using an enzyme-labeling instrument. Each group was tested in duplicate 3 times.
TABLE 4
| Relative inhibition rate | a | b | c | d |
| Tyrosine solution | 0 | 200ul | 0 | 200ul |
| Tyrosinase solution | 200ul | 200ul | 200ul | 200ul |
| Aqueous solution | 200ul | 200ul | 0 | 0 |
| PBS | 800ul | 600ul | 800ul | 600ul |
| Experimental group | 0 | 0 | 200ul | 200ul |
Tyrosinase inhibition (I) was calculated for each experimental group, I ═ 100% of [1- (Ad-Ac)/(Ab-Aa) ]. The test results are shown in table 4.
TABLE 5 tyrosinase inhibition at different concentrations in each experimental group
As can be seen from the above table, the tyrosinase inhibition rate of each experimental group gradually increased with the increase of the concentration.
Example 1 had a higher tyrosinase inhibition rate compared to the positive test group; the lactobacillus crispatus CGMCC No.6364 is contained, but the inhibition rate of the culture solution containing curcumin or cortex mori radicis extract fermentation is better than that of the simple lactobacillus crispatus CGMCC No.6364 fermentation culture (the inhibition rates of the comparative example 2 group and the comparative example 3 group are higher than that of the comparative example 1); the lactobacillus crispatus CGMCC No.6364 is replaced by the lactobacillus crispatus CGMCC1.2743 for fermentation (other culture conditions are not changed), the inhibition rate is lowest and even worse than that of the single lactobacillus crispatus CGMCC No.6364 for fermentation, which shows that the active extract of the conventional fermentation product of the lactobacillus crispatus CGMCC No.6364 has better tyrosinase inhibition rate, and the added curcumin or the mulberry bark extract has good synergistic effect, so that the tyrosinase can be greatly inhibited. Other strains of Lactobacillus crispatus did not have such outstanding efficacy.
Example 7 an exemplary embodiment of a facial mask
The whitening, freckle-removing and anti-saccharification plant fermentation composition in the embodiment 1 is added with the following raw materials to prepare a corresponding facial mask according to the parts by weight:
5 parts of a plant fermentation composition for whitening, removing freckles and resisting saccharification, 0.1 part of micromolecular hyaluronic acid, 3 parts of silk protein powder, 1 part of sodium carboxymethylcellulose, 2 parts of sodium alginate, 10 parts of cetostearyl alcohol, 5 parts of a rose extract and 200 parts of deionized water.
The preparation method of the mask comprises the following steps:
s1, respectively weighing sodium carboxymethylcellulose, cetostearyl alcohol and the like according to parts by weight, uniformly mixing, simultaneously adding a proper amount of deionized water, heating to 85-95 ℃, continuously stirring in the heating process until the deionized water is completely dissolved, and standing in a beaker for later use (component A);
s2, respectively weighing micromolecule hyaluronic acid, silk protein powder, sodium alginate and an aloe extracting solution according to parts by weight, uniformly mixing the micromolecule hyaluronic acid, the silk protein powder, the sodium alginate and the aloe extracting solution, simultaneously adding a proper amount of deionized water, heating the mixture to 70-85 ℃ until the mixture is completely dissolved, and standing the mixture in a beaker for later use (component B);
s3, weighing the whitening, freckle-removing and anti-saccharification plant fermentation composition according to parts by weight, uniformly mixing, simultaneously adding a proper amount of deionized water, heating to 55-75 ℃ until the deionized water is completely dissolved, and standing in a beaker for later use (component C);
s4, respectively stirring the component A, the component B and the component C for 8-20 min by using a high-speed shearing machine under the condition of 3000-4500 r/min to promote the dissolution of the components, and then mixing and homogenizing the component A, the component B and the component C for 7-15 min; homogenizing for 1-3 times;
s5, after homogenizing, naturally cooling the mixture until the temperature is lower than 25 ℃, and cooling and standing the mixture for 2-3 hours at room temperature to obtain the skin care product.
The prepared mask liquid has moisturizing effect, and all indexes meet relevant national regulations.
Example 8 Patch safety test
The plant fermentation composition for whitening, freckle removing and anti-saccharification is subjected to human safety study, a 1% concentration pure water solution of the plant fermentation composition for whitening, freckle removing and anti-saccharification of the invention in the embodiment 1 is used as a test group 1, and distilled water is used as a control group for testing, 30 persons in each group, and no statistical difference exists between the two groups. According to the regulation in the cosmetic hygiene code (2007 edition), more than 2 persons with skin adverse reactions of grade "++" or any 1 person with skin adverse reactions of grade "+++" or more than grade +++ "are present in 30 subjects, and the subjects are judged to have adverse reactions to human bodies. The results of the relevant tests are shown in the table below.
TABLE 6 safety test for skin patches
As shown in the table, after 0.5 hour, 24 hours and 48 hours of the spot removal tester, no adverse skin reaction is observed in the distilled water control area of 30 subjects, and no 1 case of the tested area of the whitening, spot-removing and anti-saccharification plant fermentation composition has a '++' reaction, which shows that the whitening, spot-removing and anti-saccharification plant fermentation composition has high safety and causes no adverse reaction on human skin.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (6)
1. A plant fermentation composition for whitening, removing freckles and resisting saccharification is characterized by comprising the following components in parts by weight:
(1) inoculating, fermenting and culturing the preserved lactobacillus crispatus CGMCC No.6364 into a seed solution under the aseptic condition;
(2) inoculating lactobacillus crispatus CGMCC No.6364 seed liquid into a liquid culture medium for fermentation culture;
(3) and (3) centrifuging the fermentation liquor obtained in the step (2), collecting supernatant to obtain fermentation filtrate, and filtering the fermentation filtrate by a 0.22um sterilizing filter.
2. The plant fermentation composition of claim 1, wherein step (1) is:
(1) inoculating the preserved Lactobacillus crispatus CGMCC No.6364 into MRS culture medium under aseptic condition, culturing at 35 deg.C and 200rpm for 12 hr to obtain culture as seed solution for fermentation culture with final concentration of 6 × 107cfu/ml。
3. The plant fermentation composition of claim 1 or 2, wherein step (2) is:
(2) inoculating lactobacillus crispatus CGMCC No.6364 seed liquid into a liquid culture medium according to the inoculation amount of 10 v/v%, and performing shake table culture at 30 ℃ and 200rpm for 24 hours;
the preparation method of the liquid culture medium comprises the following steps: mixing 0.3g curcumin, 50mL cortex Mori extractive solution, 25g glucose, 8g peptone, 7g yeast extract, 8g beef extract, 5g sodium acetate, 2g ammonium citrate, 2mL tween-80, 0.6g MgSO4·7H2O, 0.3g of MnSO4·4H2O, 2g of K2HPO4And 1000mL of distilled water, adjusting the pH value to 6.2-6.4, and sterilizing with high pressure steam to obtain the sterile culture medium.
4. The phytofermentation composition for whitening, freckle removal and anti-glycation according to any one of claims 1 to 3, which is made into a fermentation product cosmetic for whitening, freckle removal and anti-glycation.
5. The use according to claim 4, characterized in that it is made as a mask.
6. The use of claim 5, wherein the mask formulation comprises, by weight: 5 parts of a plant fermentation composition for whitening, removing freckles and resisting saccharification, 0.1 part of micromolecular hyaluronic acid, 3 parts of silk protein powder, 1 part of sodium carboxymethylcellulose, 2 parts of sodium alginate, 10 parts of cetostearyl alcohol, 5 parts of a rose extract and 200 parts of deionized water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010540446.9A CN111617025B (en) | 2020-06-12 | 2020-06-12 | Fermentation product cosmetic for whitening, removing freckles and resisting saccharification |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010540446.9A CN111617025B (en) | 2020-06-12 | 2020-06-12 | Fermentation product cosmetic for whitening, removing freckles and resisting saccharification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111617025A true CN111617025A (en) | 2020-09-04 |
| CN111617025B CN111617025B (en) | 2021-01-29 |
Family
ID=72255547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010540446.9A Active CN111617025B (en) | 2020-06-12 | 2020-06-12 | Fermentation product cosmetic for whitening, removing freckles and resisting saccharification |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111617025B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023186945A1 (en) * | 2022-03-30 | 2023-10-05 | Basf Beauty Care Solutions France Sas | Cosmetic, nutraceutical or dermatological use of a lactobacillus crispatus strain and/or of a composition comprising same |
| CN119454552A (en) * | 2024-05-30 | 2025-02-18 | 北京工商大学 | A fermented product of galangal, a skin external preparation containing the same, and a preparation method and application thereof |
| CN119564581A (en) * | 2024-11-25 | 2025-03-07 | 诺德溯源(广州)生物科技有限公司 | An anti-aging composition for reducing structural dark circles and eye fine lines and its application |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1357038A (en) * | 1999-06-21 | 2002-07-03 | Vsl制药有限公司 | Combinations of lactic acid bacteria and their use for the prevention and/or treatment of infections and inflammations |
| CN101904809A (en) * | 2010-07-01 | 2010-12-08 | 北京日用化学研究所 | Skin whitening composition |
| CN103502434A (en) * | 2011-05-06 | 2014-01-08 | 有机平衡医疗股份公司 | Novel lactic acid bacteria and compositions containing them |
| WO2015048511A1 (en) * | 2013-09-30 | 2015-04-02 | Elc Management Llc | Watery lotion skin care compositions and methods |
| CN104630083A (en) * | 2013-11-08 | 2015-05-20 | 苏州欧赛微科生物医药科技有限公司 | Lactobacillus crispatus and applications thereof in woman healthcare products |
| CN105286010A (en) * | 2015-09-17 | 2016-02-03 | 周学义 | A kind of beautifying and nourishing enzyme, oral liquid and production method thereof |
| CN106399192A (en) * | 2016-10-25 | 2017-02-15 | 江苏微康生物科技有限公司 | Lactic acid bacterium fermented lysate as well as preparation method and application thereof |
| CN110934803A (en) * | 2019-12-26 | 2020-03-31 | 广州金天芳颜化妆品有限公司 | Plant fermentation composition with whitening and spot-fading functions |
| KR102121540B1 (en) * | 2019-12-31 | 2020-06-10 | (주)더마랩 | Cosmetic composition containing the Stellaria media extract fermented by Lactobacillus spp. |
-
2020
- 2020-06-12 CN CN202010540446.9A patent/CN111617025B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1357038A (en) * | 1999-06-21 | 2002-07-03 | Vsl制药有限公司 | Combinations of lactic acid bacteria and their use for the prevention and/or treatment of infections and inflammations |
| CN101904809A (en) * | 2010-07-01 | 2010-12-08 | 北京日用化学研究所 | Skin whitening composition |
| CN103502434A (en) * | 2011-05-06 | 2014-01-08 | 有机平衡医疗股份公司 | Novel lactic acid bacteria and compositions containing them |
| WO2015048511A1 (en) * | 2013-09-30 | 2015-04-02 | Elc Management Llc | Watery lotion skin care compositions and methods |
| CN104630083A (en) * | 2013-11-08 | 2015-05-20 | 苏州欧赛微科生物医药科技有限公司 | Lactobacillus crispatus and applications thereof in woman healthcare products |
| CN105286010A (en) * | 2015-09-17 | 2016-02-03 | 周学义 | A kind of beautifying and nourishing enzyme, oral liquid and production method thereof |
| CN106399192A (en) * | 2016-10-25 | 2017-02-15 | 江苏微康生物科技有限公司 | Lactic acid bacterium fermented lysate as well as preparation method and application thereof |
| CN110934803A (en) * | 2019-12-26 | 2020-03-31 | 广州金天芳颜化妆品有限公司 | Plant fermentation composition with whitening and spot-fading functions |
| KR102121540B1 (en) * | 2019-12-31 | 2020-06-10 | (주)더마랩 | Cosmetic composition containing the Stellaria media extract fermented by Lactobacillus spp. |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023186945A1 (en) * | 2022-03-30 | 2023-10-05 | Basf Beauty Care Solutions France Sas | Cosmetic, nutraceutical or dermatological use of a lactobacillus crispatus strain and/or of a composition comprising same |
| CN119454552A (en) * | 2024-05-30 | 2025-02-18 | 北京工商大学 | A fermented product of galangal, a skin external preparation containing the same, and a preparation method and application thereof |
| CN119454552B (en) * | 2024-05-30 | 2025-10-24 | 北京工商大学 | A fermented product of galangal, a skin external preparation containing the same, and its preparation method and application |
| CN119564581A (en) * | 2024-11-25 | 2025-03-07 | 诺德溯源(广州)生物科技有限公司 | An anti-aging composition for reducing structural dark circles and eye fine lines and its application |
| CN119564581B (en) * | 2024-11-25 | 2025-09-23 | 诺德溯源(广州)生物科技有限公司 | Anti-aging composition for weakening structural type black eye and eye fine wrinkles and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111617025B (en) | 2021-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111617025B (en) | Fermentation product cosmetic for whitening, removing freckles and resisting saccharification | |
| KR102054793B1 (en) | Cosmetic composition Cosmetic for improving skin elasticity and reducing dark circles containing natural extract and fermented extract | |
| CN111329795B (en) | Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product | |
| CN111096941A (en) | Whitening composition containing symbiotic bacteria combined fermentation product, whitening essence and preparation method of whitening essence | |
| TW202108124A (en) | Use of solanum muricatum fermented liquid for preparing a composition for beautifying skin and/or reducing fat | |
| KR20120087408A (en) | Composition for antioxidation effect comprising sparassis crispa extract | |
| CN116807952A (en) | Active composition extracted from plant and its preparation method | |
| JP2023171950A (en) | Anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and cosmetics | |
| KR20130114808A (en) | Cosmetics composition including collagen natural fermented broth | |
| CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
| CN119112677A (en) | A eutectic microencapsulation technology and its application in cosmetics | |
| WO2021217693A1 (en) | Use of symbiotic fermentation product of hydrolyzed candida and japanese sake yeast | |
| KR101610300B1 (en) | Cosmetic Composition | |
| TWI737086B (en) | Fermentation method for increasing content of effective components in plants | |
| CN108338933B (en) | Polypeptide composition for whitening and repairing skin and application thereof | |
| KR20120054298A (en) | Composition of skin external application containing fermented soybean leaves extract | |
| CN109718158A (en) | It is a kind of using ginseng as the glossy ganoderma fermentation filtrate of culture medium and its application in cosmetics | |
| KR102453319B1 (en) | Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract | |
| TWI774168B (en) | Morus alba ferment, manufacturing method thereof and use thereof | |
| CN118948712A (en) | Anti-sugar spot-lightening composition, cosmetics and preparation method thereof | |
| CN111494302B (en) | Prebiotics whitening anti-aging fermented cosmetic | |
| CN113332192B (en) | A kind of Japanese violet fruit fermented product and its preparation method and application | |
| KR20150058635A (en) | Composition containing fermentated opuntia humifusa showing biological activity of skin | |
| CN116983237B (en) | Composition for whitening and fading spots and application thereof | |
| CN117257679B (en) | Anti-aging whitening composition, anti-aging whitening liposome and cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210111 Address after: 510000 No. 98, Hengyi Road, Longhe West Road, Longgui South Village, Baiyun District, Guangzhou City, Guangdong Province Applicant after: GUANGZHOU QIANBANG COSMETICS Co.,Ltd. Address before: 578101 1-13-101, East District, administrative center building, No.8 Yantian Road, Yangpu Economic Development Zone, Danzhou City, Hainan Province Applicant before: YANGPU JISHANG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |